Fundraising Fox

Cure Pharmaceutical

Oxnard, US · California corporation

Biotech

Founders & leadership

RD
Rob DavidsonChief Executive Officer
MU
Mark UdellChief Financial Officer

Board

WN
Wayne NasbyBoard director
IS
Ian SephtonBoard director
VB
Vic BranstetterBoard director
EM
Ed MaliskiBoard director

Reported raises · per SEC filings

Form D private placements

$8.7M disclosed across 5 rounds · 2011–2015

▶$6MraisedOct 2016 · 42 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Edward MaliskiDirector
  • Rob DavidsonExecutive Officer, Director
  • Wayne NasbyDirector
  • Ian SephtonDirector
  • Vic BranstetterDirector
  • Mark UdellExecutive Officer
Offering amount
$6M
Amount sold
$6M
Sales commissions
$253.3K
Placement agents
Colorado Financial Service Corp.
First sale
Nov 2015
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedOct 2016 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Vic BranstetterDirector
  • Ed MaliskiDirector
  • Rob DavidsonExecutive Officer, Director
  • Ian SephtonDirector
  • Wayne NasbyDirector
  • Mark UdellExecutive Officer
Offering amount
$2M
Amount sold
$2M
First sale
Jul 2011
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$323.2KraisedOct 2016 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Ian SephtonDirector
  • Wayne NasbyDirector
  • Vic BranstetterDirector
  • Rob DavidsonExecutive Officer, Director
  • Mark UdellExecutive Officer
  • Ed MaliskiDirector
Offering amount
$323.2K
Amount sold
$323.2K
First sale
Dec 2015
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$250KraisedOct 2016 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Ed MaliskiDirector
  • Wayne NasbyDirector
  • Vic BranstetterDirector
  • Mark UdellExecutive Officer
  • Rob DavidsonExecutive Officer, Director
  • Ian SephtonDirector
Offering amount
$250K
Amount sold
$250K
First sale
Jul 2015
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$80KraisedOct 2016 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Wayne NasbyDirector
  • Rob DavidsonExecutive Officer, Director
  • Ian SephtonDirector
  • Vic BranstetterDirector
  • Mark UdellExecutive Officer
  • Ed MaliskiDirector
Offering amount
$80K
Amount sold
$80K
First sale
Jun 2015
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Cure Pharmaceutical raised?
Cure Pharmaceutical has disclosed $8.7M raised across 5 rounds.
Where is Cure Pharmaceutical headquartered?
Cure Pharmaceutical is headquartered in Oxnard, US.